Halozyme Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2015
Total Assets: $181.8M
Liabilities Breakdown FY2015
Total Liabilities: $138.8M
Asset Breakdown
Total Assets: $181.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $43.3M | 23.8% |
| Accounts Receivable | $32.4M | 17.8% |
| Inventory | $9.5M | 5.2% |
| Property, Plant & Equipment | $3.9M | 2.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $92.7M | 51.0% |
Liabilities Breakdown
Total Liabilities: $138.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.5M | 3.2% |
| Long-Term Debt | $28.0M | 20.2% |
| Other Liabilities | $106.3M | 76.6% |